They treated GIPR knockout mice protected against diet induced obesity (DIO) with muGIPR-Ab or non-neutralizing GIPR antibody (CTL-Ab) for 45 days, resulting in a greater reduction in body weight of the muGIPR-Ab group, compared to control group. This evidence concerns the gene GIPR and obesity disorder.